MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 128 filers reported holding MACROGENICS INC in Q4 2015. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $6,619,000 | +5.5% | 358,161 | 0.0% | 0.28% | +1.1% |
Q2 2017 | $6,271,000 | -5.9% | 358,161 | 0.0% | 0.27% | -10.5% |
Q1 2017 | $6,662,000 | -9.0% | 358,161 | 0.0% | 0.30% | -12.4% |
Q4 2016 | $7,321,000 | -31.7% | 358,161 | 0.0% | 0.35% | -36.1% |
Q3 2016 | $10,713,000 | +23.7% | 358,161 | +11.6% | 0.54% | +12.1% |
Q2 2016 | $8,663,000 | -12.1% | 320,971 | -38.9% | 0.49% | -12.3% |
Q1 2016 | $9,853,000 | -33.9% | 525,496 | +9.2% | 0.55% | -29.6% |
Q4 2015 | $14,908,000 | +101.6% | 481,382 | +39.4% | 0.79% | +62.6% |
Q3 2015 | $7,394,000 | -30.5% | 345,208 | +23.2% | 0.48% | -41.2% |
Q2 2015 | $10,639,000 | +4.5% | 280,208 | -11.9% | 0.82% | -1.3% |
Q1 2015 | $10,180,000 | -10.1% | 317,928 | -1.5% | 0.83% | -15.2% |
Q4 2014 | $11,325,000 | +156.9% | 322,928 | +53.1% | 0.98% | +132.9% |
Q3 2014 | $4,409,000 | -3.1% | 210,957 | +0.7% | 0.42% | +1.0% |
Q2 2014 | $4,552,000 | -18.6% | 209,457 | +4.3% | 0.42% | -21.9% |
Q1 2014 | $5,590,000 | -42.7% | 200,877 | -33.0% | 0.54% | -8.1% |
Q4 2013 | $9,751,000 | – | 299,932 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 1,264,158 | $5,890,976 | 1.79% |
Bellevue Group AG | 9,803,313 | $45,683,439 | 0.74% |
Frazier Life Sciences Management, L.P. | 1,803,204 | $8,402,931 | 0.56% |
DAFNA Capital Management LLC | 258,496 | $1,204,591 | 0.38% |
SECTORAL ASSET MANAGEMENT INC | 387,001 | $1,803,425 | 0.35% |
ARMISTICE CAPITAL, LLC | 4,712,000 | $21,957,920 | 0.34% |
Rock Springs Capital Management LP | 1,178,796 | $5,493,189 | 0.15% |
GSA CAPITAL PARTNERS LLP | 225,918 | $1,053 | 0.09% |
PINNACLE ASSOCIATES LTD | 697,067 | $3,248,332 | 0.06% |
XTX Topco Ltd | 53,269 | $248,234 | 0.04% |